title: Quantification of Flavin-containing Monooxygenases 1, 3, and 5 in Human Liver Microsomes by UPLC-MRM-Based Targeted Quantitative Proteomics and Its Application to the Study of Ontogeny.
abstract: Flavin-containing monooxygenases (FMOs) have a significant role in the metabolism of small molecule pharmaceuticals. Among the five human FMOs, FMO1, FMO3, and FMO5 are the most relevant to hepatic drug metabolism. Although age-dependent hepatic protein expression, based on immunoquantification, has been reported previously for FMO1 and FMO3, there is very little information on hepatic FMO5 protein expression. To overcome the limitations of immunoquantification, an ultra-performance liquid chromatography (UPLC)-multiple reaction monitoring (MRM)-based targeted quantitative proteomic method was developed and optimized for the quantification of FMO1, FMO3, and FMO5 in human liver microsomes (HLM). A post-in silico product ion screening process was incorporated to verify LC-MRM detection of potential signature peptides before their synthesis. The developed method was validated by correlating marker substrate activity and protein expression in a panel of adult individual donor HLM (age 39-67 years). The mean (range) protein expression of FMO3 and FMO5 was 46 (26-65) pmol/mg HLM protein and 27 (11.5-49) pmol/mg HLM protein, respectively. To demonstrate quantification of FMO1, a panel of fetal individual donor HLM (gestational age 14-20 weeks) was analyzed. The mean (range) FMO1 protein expression was 7.0 (4.9-9.7) pmol/mg HLM protein. Furthermore, the ontogenetic protein expression of FMO5 was evaluated in fetal, pediatric, and adult HLM. The quantification of FMO proteins also was compared using two different calibration standards, recombinant proteins versus synthetic signature peptides, to assess the ratio between holoprotein versus total protein. In conclusion, a UPLC-MRM-based targeted quantitative proteomic method has been developed for the quantification of FMO enzymes in HLM.
authors.affiliation: Department of Pharmaceutical Chemistry, School of Pharmacy, University of Kansas, Lawrence, Kansas (Y.C., M.Z.W.); and Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, The University of North Carolina, Chapel Hill, North Carolina (N.R.Z., D.R.T.).
authors.forename: Yao
authors.initials: Y
authors.lastname: Chen
authors.affiliation: Department of Pharmaceutical Chemistry, School of Pharmacy, University of Kansas, Lawrence, Kansas (Y.C., M.Z.W.); and Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, The University of North Carolina, Chapel Hill, North Carolina (N.R.Z., D.R.T.).
authors.forename: Nicole R
authors.initials: NR
authors.lastname: Zane
authors.affiliation: Department of Pharmaceutical Chemistry, School of Pharmacy, University of Kansas, Lawrence, Kansas (Y.C., M.Z.W.); and Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, The University of North Carolina, Chapel Hill, North Carolina (N.R.Z., D.R.T.).
authors.forename: Dhiren R
authors.initials: DR
authors.lastname: Thakker
authors.affiliation: Department of Pharmaceutical Chemistry, School of Pharmacy, University of Kansas, Lawrence, Kansas (Y.C., M.Z.W.); and Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, The University of North Carolina, Chapel Hill, North Carolina (N.R.Z., D.R.T.) michael.wang@ku.edu.
authors.forename: Michael Zhuo
authors.initials: MZ
authors.lastname: Wang
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D002138:Calibration; D002648:Child; D002853:Chromatography, Liquid / Q000592:standards; D005865:Gestational Age; D006801:Humans; D008099:Liver / Q000196:embryology / Q000201:enzymology*; D008862:Microsomes, Liver / Q000201:enzymology*; D008875:Middle Aged; D010105:Oxygenases / Q000378:metabolism*; D040901:Proteomics / Q000379:methods* / Q000592:standards; D012015:Reference Standards; D015203:Reproducibility of Results; D053719:Tandem Mass Spectrometry
chemical_list: D010105:Oxygenases; C020066:dimethylaniline monooxygenase (N-oxide forming)
references.citation: Curr Drug Metab. 2000 Sep;1(2):181-91
references.pmid: 11465082
references.citation: J Toxicol Sci. 2009;34 Suppl 2:SP307-12
references.pmid: 19571484
references.citation: Proteomics. 2008 Oct;8(20):4186-96
references.pmid: 18792928
references.citation: Drug Metab Dispos. 2010 Jan;38(1):25-31
references.pmid: 19841059
references.citation: Drug Metab Dispos. 2000 Sep;28(9):1107-11
references.pmid: 10950857
references.citation: Pediatr Res. 2002 Feb;51(2):236-43
references.pmid: 11809920
references.citation: Electrophoresis. 2009 Apr;30(7):1248-57
references.pmid: 19283698
references.citation: Anal Biochem. 2008 Sep 15;380(2):211-22
references.pmid: 18558078
references.citation: Curr Drug Metab. 2008 May;9(4):280-4
references.pmid: 18473746
references.citation: Pharmacol Ther. 2005 Jun;106(3):357-87
references.pmid: 15922018
references.citation: Drug Metab Dispos. 2015 Jul;43(7):1045-55
references.pmid: 25926430
references.citation: Biochem Pharmacol. 1998 Oct 15;56(8):1005-12
references.pmid: 9776311
references.citation: Chem Biol Interact. 1997 Aug 29;106(1):29-45
references.pmid: 9305407
references.citation: Annu Rev Pharmacol Toxicol. 2006;46:65-100
references.pmid: 16402899
references.citation: Drug Metab Dispos. 2014 Jan;42(1):78-88
references.pmid: 24122874
references.citation: Pharm Res. 2008 Jun;25(6):1469-83
references.pmid: 18219561
references.citation: Anal Chem. 2006 Feb 15;78(4):1071-84
references.pmid: 16478097
references.citation: Drug Metab Lett. 2008 Aug;2(3):210-22
references.pmid: 19356096
references.citation: Drug Metab Dispos. 1993 Jul-Aug;21(4):587-97
references.pmid: 8104117
references.citation: Chem Res Toxicol. 1995 Mar;8(2):166-81
references.pmid: 7766799
references.citation: Drug Metab Dispos. 2014 Aug;42(8):1241-51
references.pmid: 24816681